Monday, 21 April 2014

Fungal contamination of pharmaceutical products


The second most common reason for the recall of pharmaceutical products is fungal contamination. To assess current trends and to evaluate risks, Tim Sandle has written an article for the European Pharmaceutical Review.

Most reports relating to the contamination of pharmaceutical products centre on bacterial contamination rather than fungi. The reasons for this may relate to few 'microbiology' laboratories in pharmaceutical organisations having trained mycologists; to an underestimation of the association between fungi and product contamination incidents; and due to a lack of appreciation of the risks that fungi can pose to cleanrooms and controlled environments. This article considers some of these issues and, in doing so, argues that the contamination risk posed by fungi to pharmaceutical products is greater than the level of industrial and academic interest would suggest.

The reference for the article is:

Sandle, T. (2014) Fungal contamination of pharmaceutical products: the growing menace, European Pharmaceutical Review, 19 (1): 68-71

For further details, please contact Tim Sandle

Posted by Tim Sandle